The inhibition of B7H4 glycosylation can be favourably combined with immunogenic chemotherapy and PD-L1 blockade to achieve superior immuno-infiltration of cold tumours and improved tumour growth control [27,157]. The gene discussed is VTCN1; the disease is neoplasm.